Post-marketing safety of immunomodulatory drugs in multiple myeloma: A pharmacovigilance investigation based on ..

Objective: In recent years, the emergence of immunomodulatory drugs (IMiDs) has significantly improved clinical outcomes in patients with multiple myeloma…

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top